Grace Therapeutics, Inc.
$2.10
-0.03 (-1.41%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +1.0%
- 3 Months
- -16.0%
- YTD
- -39.3%
- 1 Year
- -30.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 70.2%
- Largest decline max drawdown, since Aug 2025
- -59.6%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.10
Own GRCE?
See how GRCE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.